Kobayashi, Shin
Nakamura, Yoshiaki
Takahashi, Shinichiro
Taniguchi, Hiroya
Yoshino, Takayuki
Funding for this research was provided by:
National Cancer Center Japan (Research Development Fund / 30-A-8)
Article History
Received: 23 November 2020
Accepted: 23 November 2020
First Online: 4 January 2021
Disclosure
: The authors disclose potential conflicts of interest as follows: Yoshiaki Nakamura, research funding from Taiho pharmaceutical company and Genomedia Inc.; Hiroya Taniguchi, honoraria from Takeda, Chugai, and Taiho pharmaceutical companies. Research funding from Takeda, Daiichi-Sankyo, Taiho, Ono Pharmaceutical companies; Takayuki Yoshino, research funding from Novartis Pharma, MSD, Sumitomo Dainippon Pharma, Chugai Pharmaceutical, Sanofi, Daiichi Sankyo, Parexel International, Ono Pharmaceutical, and GlaxoSmithKline companies.